Adiponectin and Cardiovascular Outcomes among Hemodialysis Patients

Publisher： Karger

E-ISSN： 1423-0143|35|4|247-253

ISSN： 1420-4096

Source： Kidney and Blood Pressure Research, Vol.35, Iss.4, 2012-01, pp. : 247-253

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

CCN2 (CTGF) Gene Polymorphism Is a Novel Prognostic Risk Factor for Cardiovascular Outcomes in Hemodialysis Patients

By  

Blood Purification, Vol. 30, Iss. 4, 2010-11 ,pp. : 272-276

Karger

Access to resources Recommend Favorite

Predictive Value of Atrial Electromechanical Delay on Long-Term Cardiovascular Outcomes in Hemodialysis Patients

By  

American Journal of Nephrology, Vol. 42, Iss. 3, 2015-0 ,pp. : 239-249

Karger

Access to resources Recommend Favorite

Associations among Darbepoetin-α, CD34+ Cells and Cardiovascular Disease Events in Patients on Hemodialysis

By  

Nephron Extra, Vol. 2, Iss. 1, 2012-09 ,pp. : 233-246

Karger

Access to resources Recommend Favorite

Association of Plasma Adiponectin Levels with Oxidative Stress in Hemodialysis Patients

By  

Blood Purification, Vol. 25, Iss. 4, 2007-08 ,pp. : 362-369

Karger

Access to resources Recommend Favorite

Proven Strategies to Reduce Cardiovascular Mortality in Hemodialysis Patients

By  

Blood Purification, Vol. 24, Iss. 1, 2005-12 ,pp. : 100-106

Karger

Access to resources Recommend Favorite